|They fear that funding support for their vast gene-mapping project could erode now that the Nobelist is leaving|
Genome scientists interviewed for this article say it will be difficult for the National Institutes of Health, via its search committee, to find someone with the same drive, vision, and scientific stature--which, they generally agree, translates into an ongoing ability to obtain high-priority funding from Congress.
Preceding the resignation was well-publicized friction between the Nobel Prize-winning Watson--noted both for his achievement in identifying the double helix structure of DNA and for his outspokenness--and NIH director Bernadine Healy.
Recently Watson lashed out at Healy over her support of NIH's pursuit of patents on partial DNA sequences,...
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?